(800) 267-1555
/
Contact Us
  • Login
  • English
    • Français
Canadian Psychiatric Association – Association des psychiatres du Canada Canadian Psychiatric Association – Association des psychiatres du Canada Canadian Psychiatric Association – Association des psychiatres du Canada
Navigation
  • Home
  • About
    • Who We Are
      • Board of Directors
      • Governance Structure
      • Staff
      • Past Presidents & Board Chairs
    • Strategic Plan & Priorities
    • Annual Reports
    • Foundation of the CPA
    • Collaborations & Partnerships
  • Membership
    • Why Belong – Benefits of Membership/Affiliation
      • Affinity Benefits
    • How to Join
      • Individual
      • Organization
    • Member Recognition
      • Awards
      • Fellowships
    • Junior Investigator Research Colloquium
    • Mentorship Program
  • News, Advocacy & Policy
    • Newsroom
      • News Releases
      • CPA in the News
      • Media Contact
    • Advocacy & Policy
      • Position Papers & Statements
      • Briefs
      • Medical Assistance in Dying (MAiD)
    • Career Opportunities
    • Links
  • Clinical Resources
    • The Canadian Journal of Psychiatry
    • Clinical Practice Guidelines
    • Position Papers & Statements
    • Collaborative Documents
    • Books
  • CPD
    • Accreditation
    • Calendar of Events
  • Annual Conference
  • COVID-19

Category: Choosing Wisely

Home Blog Choosing Wisely

02

Jun2015

First-line treatment for insomnia should not include routine use of antipsychotics, say Canadian psychiatrists

0   0
June 2, 2015
Ottawa, ON, June 2, 2015— The routine use of antipsychotics, like Zyprexa (olanzapine) and Seroquel (quetiapine), should not be used to treat primary insomnia in children, adults or the elderly, say Canadian psychiatrists. This information is part of a series of 13 evidence-based recommendations made by the Canadian Psychiatric Association ... Read More
June 2, 2015Rob Cornforth
Disclaimer | Privacy Policy | Terms of Use | Contact Us
Exhibitor Floor Plan 2022